The mRNA era is here. MPM believes the future belongs to oRNA — and Big Pharma wants a seat at the table

February 24, 2021 – If the ultra-fast clinical development of Covid-19 vaccines opened the world’s eyes to the promises of messenger RNA, the subsequent delays in supply offered a crash course on the ultra-complex process of producing them.